Schünemann H, Willich N
Abteilung Gynäkologie I, Onkologische Klinik Bad Trissl, Oberaudorf.
Dtsch Med Wochenschr. 1997 Apr 25;122(17):536-41. doi: 10.1055/s-2008-1047650.
According to published reports, the incidence of lymphoedema of the arm in patients with cancer of the breast, treated by either surgery or radiotherapy, varies widely. We obtained basic data on the treatment of breast cancer in a large number of patients in order to determine the relationship between the incidence of lymphoedema and the radical nature of the primary treatment.
Data were collected on all women with lymphoedema of the arm after treatment for breast cancer between 1972 and 1995. The increase in arm circumference was measured by a standardised method. Only those patients were included in the final analysis whose arm circumference had increased by at least 2 cm. The type of operation and(or) radiotherapy, tumor histology and TNM classification were recorded.
There were 1405 cases of arm lymphoedema after treatment of 5868 cases of breast cancer (24%). 2515 breast cancers had been treated surgically. 3353 surgically and by radiotherapy. Lymphoedema occurred in 22.3% after radical mastectomy without radiotherapy and in 44.4% with it; after modified radical mastectomy without radiotherapy in 19.1%, in 28.9% with radiotherapy; after breast-preserving operation without radiotherapy in 6.7%, with radiotherapy in 10.1%. Until the 1970s radical mastectomy with conventional postoperative radiotherapy has been the treatment of choice, with 38% cases of lymphoedema. This incidence gradually decreased to 16% in subsequent years.
The incidence of lymphoedema of the arm depends on the radical nature of the primary treatment. The quality of life could be easily improved through minimising the incidence of lymphoedema if current standards of breast-preserving surgery were generally practised.
根据已发表的报告,接受手术或放疗治疗的乳腺癌患者手臂淋巴水肿的发生率差异很大。我们获取了大量患者的乳腺癌治疗基础数据,以确定淋巴水肿发生率与初始治疗的根治性之间的关系。
收集了1972年至1995年间接受乳腺癌治疗后出现手臂淋巴水肿的所有女性的数据。采用标准化方法测量手臂周长的增加。最终分析仅纳入手臂周长至少增加2厘米的患者。记录手术和(或)放疗的类型、肿瘤组织学及TNM分类。
5868例乳腺癌患者治疗后有1405例出现手臂淋巴水肿(24%)。2515例乳腺癌接受了手术治疗,3353例接受了手术及放疗。根治性乳房切除术后未放疗淋巴水肿发生率为22.3%,放疗后为44.4%;改良根治性乳房切除术后未放疗为19.1%,放疗后为28.9%;保乳手术后未放疗为6.7%,放疗后为10.1%。直到20世纪70年代,传统术后放疗的根治性乳房切除术一直是首选治疗方法,淋巴水肿发生率为38%。在随后几年中,这一发生率逐渐降至16%。
手臂淋巴水肿的发生率取决于初始治疗的根治性。如果普遍采用当前保乳手术标准,通过降低淋巴水肿发生率可轻松改善生活质量。